source
- Pharma leaders risk industry collapse by over-relying on Chinese drug sourcing, says analystOlivia Kosloff, a senior fellow at the American Economic Liberties Project and co-chair of a Council on Foreign Relations working group, argues that U.S. pharma and biotech executives are jeopardiz…
- Eli Lilly suggests low-dose Zepbound and Foundayo could safely maintain weight loss at lower costNew trial data indicate that lowering the dose of Eli Lilly's obesity injection Zepbound may still provide effective weight‑loss maintenance while improving safety. The study also highlights Found…